Internal Medicine, Pulmonary Disease · Oklahoma City, OK
NPI
1992895478
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5608 SE 67th St Ste 106
Oklahoma City, OK, 73135
Phone (405) 757-0150
Groups this clinician bills Medicare through
Medicare paid, 2024
$601K
9,108 services
Medicare patients, 2024
2,574
Average age 75
Drug cost, 2024
$6.1M
7,689 prescriptions
Company payments, 2025
$3,096
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shoab Nazir was code 99215 (office e&m - established), 2,439 times for 1,678 patients. In total Shoab Nazir billed 9,108 services in 45 codes, and Medicare paid $601K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 2,439 | 1,678 | $121.99 | $298K |
| 71046 X-ray - Chest | Office | 1,699 | 1,357 | $22.34 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 803 | 738 | $12.07 | $9,689 |
| 94727 Pulmonary Function Testing | Office | 628 | 628 | $28.81 | $18K |
| 94729 Pulmonary Function Testing | Office | 628 | 628 | $36.58 | $23K |
| 99204 Office E&M - New | Office | 419 | 419 | $111.19 | $47K |
| 99232 Hospital E&M - Subsequent | Facility | 404 | 167 | $56.82 | $23K |
| 99205 Office E&M - New | Office | 374 | 374 | $149.28 | $56K |
| 94060 Pulmonary Function Testing | Office | 329 | 329 | $25.86 | $8,506 |
| 94010 Pulmonary Function Testing | Office | 299 | 299 | $18.31 | $5,476 |
| 99233 Hospital E&M - Subsequent | Facility | 223 | 100 | $85.25 | $19K |
| 99214 Office E&M - Established | Office | 195 | 182 | $77.35 | $15K |
| 94664 E&M - Miscellaneous | Office | 162 | 158 | $11.86 | $1,921 |
| 99223 Hospital E&M - Initial | Facility | 143 | 128 | $123.18 | $18K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 79 | 77 | $31.69 | $2,504 |
By year: 2022 $367K for 6,439 services; 2023 $565K for 7,194 services; 2024 $601K for 9,108 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shoab Nazir prescribed most often to Medicare patients was Montelukast Sodium, with 1,335 prescriptions and refills. In total Shoab Nazir wrote 7,689 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,335 | 3,660 | 461 | $24K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 824 | 1,621 | 354 | $36K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 731 | 1,474 | 237 | $932K |
| Prednisone Generic | 609 | 842 | 402 | $2,359 |
| Azithromycin Generic | 458 | 1,016 | 209 | $10K |
| Ipratropium Bromide Generic | 457 | 884 | 198 | $21K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 375 | 728 | 137 | $453K |
| Ofev Nintedanib Esylate | 269 | 275 | 45 | $3.5M |
| Fluticasone Propionate Generic | 265 | 543 | 122 | $7,706 |
| Spiriva Respimat Tiotropium Bromide | 248 | 431 | 86 | $220K |
| Breo Ellipta Fluticasone/Vilanterol | 246 | 440 | 67 | $171K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 138 | 306 | 60 | $26K |
| Doxycycline Hyclate Generic | 108 | 120 | 96 | $844 |
| Roflumilast Generic | 107 | 207 | 26 | $9,529 |
| Pantoprazole Sodium Generic | 96 | 259 | 46 | $1,959 |
Brand drugs: 2,859 claims; generic drugs: 4,830 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shoab Nazir $3,096 ($3,096 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $651.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $651 |
| GlaxoSmithKline, LLC. GSK | 29 | $478 |
| Insmed, Inc. INSM | 15 | $290 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $250 |
| Harmony Biosciences LLC HRMY | 10 | $214 |
| Viatris Specialty LLC | 15 | $156 |
| Inspire Medical Systems, Inc. INSP | 2 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $146 |
| Genzyme Corporation SNY | 10 | $144 |
| United Therapeutics Corporation UTHR | 5 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.